RKDA Arcadia Biosciences
- 6.3500
- +0.1300+2.09%
- 6.3500
- 0.00000.00%
Arcadia Biosciences News
Arcadia Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Arcadia Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Arcadia Biosciences | 10-Q: Q3 2024 Earnings Report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights
Arcadia Biosciences | 8-K/A: Current report (Amendment)
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Yoder Amy
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director WALLER GREGORY D
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Murray Lilian Shackelford
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Carosella Deborah D
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Bolles Albert D.
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Comcowich Kevin
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Kawakami Mark
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Schaefer Thomas J.
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Kawakami Mark
Arcadia Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Schaefer Thomas J.
Arcadia Biosciences | 10-Q: Q2 2024 Earnings Report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
No Data